Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes ; volume:11 ; number:1 ; day:14 ; month:9 ; year:2012 ; pages:1-8 ; date:12.2012
Cardiovascular diabetology ; 11, Heft 1 (14.9.2012), 1-8, 12.2012
- Urheber
-
Fujishima, Yuya
Maeda, Norikazu
Inoue, Kana
Kashine, Susumu
Nishizawa, Hitoshi
Hirata, Ayumu
Kozawa, Junji
Yasuda, Tetsuyuki
Okita, Kohei
Imagawa, Akihisa
Funahashi, Tohru
Shimomura, Iichiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1475-2840-11-107
- URN
-
urn:nbn:de:101:1-2021082820441541254287
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fujishima, Yuya
- Maeda, Norikazu
- Inoue, Kana
- Kashine, Susumu
- Nishizawa, Hitoshi
- Hirata, Ayumu
- Kozawa, Junji
- Yasuda, Tetsuyuki
- Okita, Kohei
- Imagawa, Akihisa
- Funahashi, Tohru
- Shimomura, Iichiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucagon-like peptide 1 (GLP-1)
Comprehensive characterization of cardiovascular protection by the GLP-1 (Glucagon-like peptide-1) analog liraglutide in experimental arterial hypertension
Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Glucagon-like peptide 1 (GLP-1)
Comprehensive characterization of cardiovascular protection by the GLP-1 (Glucagon-like peptide-1) analog liraglutide in experimental arterial hypertension
Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Glucagon-like peptide 1 (GLP-1)
Comprehensive characterization of cardiovascular protection by the GLP-1 (Glucagon-like peptide-1) analog liraglutide in experimental arterial hypertension
Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?